Bone mass anabolic composition

摘要

The present invention provides methods for bone mass anabolic preservation or augmentation in human or other animal subjects affected by osteoporosis or other metabolic bone disorder characterized by systemic or regional bone loss, using bisphosphonates formulations, wherein the bone mass anabolic composition contains effective non-toxic doses of [3-(N,N-dimethylamine)-1-hydroxypropylidene]-bisphosphonic acid or olpadronate or the monosodium or other pharmaceutically acceptable salt thereof.